People

Josh Mandel-Brehm

Josh Mandel-Brehm

Josh Mandel-Brehm serves as President & Chief Executive Officer at CAMP4 Therapeutics. Biotechnology executive with prior business development experience at Biogen and Genzyme and entrepreneurship experience with Polaris Partners; also serves on the ProMIS Neurosciences board.

Roles

ProMIS Neurosciences

Independent Director

Current
CAMP4 Therapeutics

President & Chief Executive Officer

Current
Current